Anemocyte is proud to announce its sponsorship and exhibition at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place from May 13–17, 2025, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. As a leading Biotech Manufacturing Organization (BMO), Anemocyte is committed to advancing the field of cell and gene therapy through innovative manufacturing solutions.
The ASGCT Annual Meeting is the premier event for professionals in gene and cell therapy, offering a platform to learn about the latest scientific research, stay current on new technologies, and make career-advancing connections. With over 2,100 presentations across plenaries, parallel sessions, oral abstracts, and posters, attendees will experience groundbreaking research firsthand.
Key Highlights of ASGCT 2025: cutting edge research and industry leaders
- Scientific Sessions: explore cutting-edge research through a variety of presentations and discussions.
- Networking Opportunities: engage with peers and leaders in the field at events such as the Women in Gene & Cell Therapy Reception, Career Fair, and Closing Night Reception.
- Exhibit Hall: discover the latest products and services from industry leaders in the largest exhibit hall yet.
Sponsorship and booth: discover our advanced manufacturing solutions
Anemocyte invites attendees to visit our booth to learn more about our advanced manufacturing solutions and discuss potential collaborations. Our team is eager to connect with researchers, clinicians, and industry professionals to explore how we can support the development of transformative therapies.
For more information about the ASGCT 2025 Annual Meeting and to register, please visit the official ASGCT Annual Meeting website
